Delivery Order SPE2DB20D2104-SPE2DB24FU48R
Award Date 6/1/24
Potential Completion Date 6/3/24
Potential Value $2.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,715.99 firm-fixed-price contract is for the delivery of LINZESS 72 MCG CAPSULE UU 30S pharmaceutical products. The contract has a completion date of May 23, 2025 and is not set aside for any socioeconomic program. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,477.17 firm fixed-price contract is for the supply of LINZESS 145 MCG CAPSULE medical products, with a period of performance through February 27, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of LINZESS 145 MCG capsules. The contract has a firm fixed price of $4,196.85 and a period of performance through August 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to $999,999,999, for delivering a wide range of pharmaceutical and medical supplies to support military...
- This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is valued at $1,496.56 and has an ultimate completion date of June 10, 2025. The award is for the delivery of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of LINZESS 290 MCG capsules. The $1,764.96 firm-fixed-price contract has a completion date of November 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LINZESS 145 MCG capsules. The contract has a ceiling value of $1,882.29 and a completion date of September 17, 2024. It is a firm-fixed-price contract and does not have a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor. The award is for the pharmaceutical product LINZESS 145 MCG CAPSULE in 30-count units, with a ceiling value of $2,635.63 and a performance period through April 5, 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, specializes in providing pharmaceuticals and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,261.98 fixed-price delivery order is for the supply of LINZESS 145 MCG capsules and has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of LINZESS 145 MCG capsules. The ceiling value of the contract is $3,617.28 and the ultimate completion date is November 17, 2023. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LINZESS 72 MCG CAPSULE medical products, with a ceiling value of $1,624.42 and a period of performance through May 9, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...